Related Experiment Video
Updated: Mar 14, 2026
11:53
Predicting Gene Silencing Through the Spatiotemporal Control of siRNA Release from Photo-responsive Polymeric Nanocarriers
Published on: July 21, 2017
7.8K
Revolutionizing Drug and Gene Delivery: Cutting-Edge Smart Polymers for Precision Release
Atul Pratap Singh1, Shamim1, Dhananjay Taumar1
1Department of Pharmacy, IIMT University, O-Pocket Ganga Nagar, Meerut 250001, India.
Current Gene Therapy
|March 12, 2026
Summary
Smart polymers offer advanced drug and gene delivery with stimuli-responsive release for enhanced specificity and reduced toxicity. This review explores innovations in smart polymers for targeted therapy and theranostics.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Pharmacology
Background:
- Smart polymers offer stimuli-responsive drug and gene delivery, improving therapeutic specificity, efficacy, and safety over traditional carriers.
- These dynamic materials enable controlled, site-specific release triggered by physiological cues like pH, temperature, or enzymes.
- Smart polymers enhance bioavailability and minimize systemic toxicity through accurate drug delivery.
Purpose of the Study:
- To review recent advancements in stimuli-responsive polymers, multifunctional nanoplatforms, and hybrid polymer systems for drug delivery.
- To highlight the potential of these smart polymer systems in controlled drug delivery and theranostics.
- To discuss challenges and future directions in smart polymer-based therapeutics, including biocompatibility and overcoming biological barriers.
Main Methods:
- Literature review of recent developments in stimuli-responsive polymers and nanocarriers.
- Analysis of functional nanoplatforms and hybrid polymer systems for drug and gene delivery.
- Discussion of challenges such as biocompatibility, stability, and overcoming biological barriers like the blood-brain barrier.
Main Results:
- Smart polymers demonstrate significant potential for stimuli-responsive, controlled drug and gene delivery.
- Multifunctional nanoplatforms and hybrid systems offer enhanced therapeutic capabilities and theranostic applications.
- Progress is being made in addressing challenges related to biocompatibility and targeted delivery across biological barriers.
Conclusions:
- Smart polymer-based systems are revolutionizing therapeutics by enabling precise, targeted drug and gene delivery.
- Combining smart polymers with nanotechnology and personalized medicine will redefine targeted therapy and maximize patient outcomes.
- Further research into overcoming biological barriers and ensuring long-term biocompatibility is crucial for clinical translation.
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
79
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
79
01:24Modified-Release Drug Delivery Systems: Site-Targeted
70
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
70
01:23Modified-Release Drug Delivery Systems: Classification
167
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
167
01:29Microorganisms in Medicine and Therapeutics
1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
73
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
73
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
68
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
68